The Economic Times reports that GE Aerospace and Hindustan Aeronautics Limited are “inching closer” to seal a jet engine deal. The same coverage notes this involves technology transfer arrangements worth billions. What the reporting does not mention is which board approved the preliminary terms, what the governance structure for technology sharing looks like, or how intellectual property risks are being allocated.

Joint ventures in aerospace typically involve decade-long commitments with complex IP licensing, regulatory compliance across multiple jurisdictions, and staged capital deployment. For HAL, a government-controlled entity, this means additional layers of oversight from the Defence Ministry and potential scrutiny from the Comptroller and Auditor General.

The technology transfer component raises specific board-level questions. When US companies transfer sensitive technology to Indian defence manufacturers, the arrangement often includes milestone-based disclosures, audit rights, and compliance certifications that extend beyond standard commercial contracts.

GE’s board would need to evaluate how this partnership fits within their broader defence portfolio strategy, particularly given ongoing geopolitical considerations around technology sharing with non-NATO allies. The deal structure likely includes provisions for government intervention, force majeure related to policy changes, and potentially export control compliance that could affect GE’s other defence contracts.

For HAL, the governance challenge is different. As a PSU, their board composition includes government nominees who must balance commercial viability with strategic defence objectives. The approval process for such partnerships typically requires clearance from multiple ministries, creating a complex stakeholder management situation for the board.

What remains unclear from current reporting is the timeline for board approvals, whether preliminary agreements are already in place, and how the companies are structuring risk allocation for potential regulatory changes in either jurisdiction.

My Boardroom Takeaway

Directors evaluating similar cross-border technology partnerships should focus on three areas: ensuring due diligence covers regulatory approval timelines in both jurisdictions, structuring clear exit mechanisms if government policies change, and establishing independent oversight of IP transfer milestones. The documentation trail for such deals often becomes critical during later regulatory reviews.